CSIMarket
 


China Biologic Products Holdings Inc   (CBPO)
Other Ticker:  
 

China Biologic Products Holdings Inc 's Tangible Leverage Ratio

CBPO's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth




CBPO Tangible Leverage Ratio (Dec 31 2019)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2018)
IV. Quarter
Y / Y Tangible Equity Change -0.78 % -0.78 % -0.78 % -0.78 % 122.46 %
Y / Y Total Liabilities Change -43.39 % -43.39 % -43.39 % -43.39 % 36.55 %
Tangible Leverage Ratio MRQ 0.11 0.11 0.11 0.11 0.19
Overall Ranking # 162 # 158 # 0 # 0 # 378
Seq. Tangible Equity Change 0 % 0 % 0 % -0.78 % 0 %
Seq. Total Liabilities Change 0 % 0 % 0 % -43.39 % 0 %



Tangible Leverage Ratio forth quarter 2019 Comment
Due to repayements of liabilities of 0% China Biologic Products Holdings Inc improved Tangible Leverage Ratio in forth quarter 2019 to 0.11, below company's average Tangible Leverage Ratio.

Within Biotechnology & Pharmaceuticals industry in the forth quarter 2019, 21 other companies have achieved lower Tangible Leverage Ratio than China Biologic Products Holdings Inc . While Tangible Leverage Ratio total ranking has deteriorated compare to the previous quarter from 158 to 162.

Explain Tangible Leverage Ratio?
What is CBPO Market Share?
Tangible Leverage Ratio forth quarter 2019 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 22
Healthcare Sector # 74
Overall Market # 162


Tangible Leverage Ratio Statistics
High Average Low
0.93 0.4 0.09
(Sep 30 2014)   (Dec 31 2019)




Financial Statements
China Biologic Products Holdings Inc 's Tangible Equity $ 1,466 Millions Visit CBPO's Balance sheet
China Biologic Products Holdings Inc 's Total Liabilities $ 163 Millions Visit CBPO's Balance sheet
Source of CBPO's Sales Visit CBPO's Sales by Geography


Cumulative China Biologic Products Holdings Inc 's Tangible Leverage Ratio

CBPO's Tangible Leverage Ratio for the trailling 12 Months

CBPO Tangible Leverage Ratio

(Dec 31 2019)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2018)
IV. Quarter
Y / Y Tangible Equity TTM Growth -0.78 % -0.78 % -0.78 % -0.78 % 122.46 %
Y / Y Total Liabilities TTM Growth -43.39 % -43.39 % -43.39 % -43.39 % 36.55 %
Tangible Leverage Ratio TTM 0.11 0.13 0.15 0.17 0.19
Total Ranking TTM # 172 # 172 # 172 # 0 # 100
Seq. Tangible Equity TTM Growth 0 % 0 % 0 % -0.78 % 0 %
Seq. Total Liabilities TTM Growth 0 % 0 % 0 % -43.39 % 0 %


TTM Tangible Leverage Ratio Comment
On the trailing twelve months basis Due to repayements of liabilities of 0% China Biologic Products Holdings Inc decreased Tangible Leverage Ratio in the IV. Quarter to 0.11, below company's average Tangible Leverage Ratio.
Tangible Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Biotechnology & Pharmaceuticals industry 15 other companies have achieved lower Tangible Leverage Ratio than China Biologic Products Holdings Inc . While total ranking remained unchanged compare to previous quarter at no. 172.

Explain Tangible Leverage Ratio?
What is CBPO Market Share?

TTM Tangible Leverage Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 16
Healthcare Sector # 56
Within the Market # 172


TTM Tangible Leverage Ratio Statistics
High Average Low
0.62 0.28 0.09
(Dec. 30, 2014)   (Dec 31 2018)




Companies with similar Tangible Leverage Ratio in the quarter ending Dec 31 2019, within Biotechnology & Pharmaceuticals Industry Tangible Leverage RatioDec 31 2019 MRQ Total LiabilitiesDec 31 2019 MRQ Tangible Equity
X4 Pharmaceuticals Inc  0.30 $ 30.580  Millions$ 102.111  Millions
Solid Biosciences Inc   0.29 $ 23.423  Millions$ 80.048  Millions
Oncocyte Corporation  0.29 $ 9.021  Millions$ 30.838  Millions
Orchard Therapeutics Plc  0.28 $ 84.768  Millions$ 299.193  Millions
Replimune Group Inc   0.27 $ 52.858  Millions$ 197.565  Millions
Seagen Inc   0.25 $ 329.579  Millions$ 1,301.616  Millions
Intellia Therapeutics Inc   0.24 $ 64.399  Millions$ 269.881  Millions
Vir Biotechnology Inc   0.24 $ 88.129  Millions$ 371.311  Millions
Fate Therapeutics Inc   0.24 $ 57.518  Millions$ 244.756  Millions
Lineage Cell Therapeutics Inc   0.22 $ 11.296  Millions$ 52.327  Millions
Anavex Life Sciences Corp   0.21 $ 5.464  Millions$ 25.960  Millions
Capstone Companies Inc   0.21 $ 0.636  Millions$ 3.041  Millions
Rubius Therapeutics Inc   0.21 $ 57.179  Millions$ 274.213  Millions
Achieve Life Sciences Inc   0.20 $ 3.028  Millions$ 14.929  Millions
Homology Medicines Inc  0.20 $ 52.060  Millions$ 258.507  Millions
Fennec Pharmaceuticals Inc   0.19 $ 2.271  Millions$ 11.875  Millions
Immunitybio inc   0.19 $ 22.444  Millions$ 120.679  Millions
Intuitive Surgical Inc   0.18 $ 1,469.400  Millions$ 7,977.500  Millions
Atara Biotherapeutics Inc   0.18 $ 52.161  Millions$ 290.781  Millions
Jounce Therapeutics inc   0.18 $ 31.289  Millions$ 174.593  Millions
Microbot Medical Inc   0.18 $ 5.586  Millions$ 31.540  Millions
Mymd Pharmaceuticals Inc   0.17 $ 1.530  Millions$ 9.185  Millions
Lakeland Industries Inc.  0.16 $ 13.518  Millions$ 84.181  Millions
Casi Pharmaceuticals inc   0.16 $ 8.966  Millions$ 56.100  Millions
Alpha Pro Tech Ltd   0.15 $ 4.864  Millions$ 33.161  Millions
Nexien Biopharma Inc   0.14 $ 0.019  Millions$ 0.128  Millions
Allogene Therapeutics Inc   0.14 $ 88.779  Millions$ 628.872  Millions
Crispr Therapeutics Ag  0.14 $ 127.327  Millions$ 939.190  Millions
Ladrx Corporation  0.13 $ 2.050  Millions$ 15.205  Millions
Immunovant Inc   0.13 $ 14.757  Millions$ 111.862  Millions

Date modified: 2022-05-19T16:22:37+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

IMKTA's Profile

Stock Price

IMKTA's Financials

Business Description

Fundamentals

Charts & Quotes

IMKTA's News

Suppliers

IMKTA's Competitors

Customers & Markets

Economic Indicators

IMKTA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071